City

Bloomsbury (1)

Cambridge (1)

Cleveland (1)

Glasgow (1)

London (1)

Manchester (1)

Oxford (1)

Sutton (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Case Comprehensive Cancer Center (1)

Nurix Therapeutics, Inc. (1)

Collaborator

Intervention

nivolumab (1)

nx-1607 (1)

talazoparib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

metastatic or unresectable melanoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)

Recruiting

Ovarian Cancer, Epithelial
+14 more

NX-1607

Sutton, Surrey, United Kingdom
+6 more

Jul 22, 2022

Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

Recruiting

Metastatic or Unresectable Melanoma

Cleveland, Ohio

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca

Mar 22, 2022